First Generic Versions of Celebrex Approved

The FDA has granted approval for the first generic versions of Celebrex (celecoxib; Pfizer) capsules.

Teva has been approved to market Celecoxib Capsules in 50mg, 100mg, 200mg, and 400mg strengths. Mylan has been approved to market Celecoxib Capsules in a 50mg strength.

Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis (AS), juvenile rheumatoid arthritis (JRA), dysmenorrhea, and acute pain.

RELATED: Antirheumatic Indications: NSAIDs

The mechanism of action is believed to be due to inhibition of prostaglandin synthesis, primarily via inhibition of cyclooxygenase-2 (COX-2), and at therapeutic concentrations in humans, celecoxib does not inhibit the cyclooxygenase-1 (COX-1) isoenzyme.

For more information visit or